Faron Pharmaceuticals Oy carries a market capitalization of 47.90M, placing it among publicly traded companies globally.
| Market Cap | 47.90M |
| Enterprise Value | N/A |
Faron Pharmaceuticals Oy's stock has declined approximately -80.46512% over the past 52 weeks. The 50-day moving average sits at 43.07, while the 200-day moving average is 110.50.
| Beta (5Y) | N/A |
| 52-Week Price Change | -80.46512% |
| 50-Day Moving Average | 43.07 |
| 200-Day Moving Average | 110.50 |
| Average Volume (20 Days) | N/A |
Faron Pharmaceuticals Oy's most recent stock split took place on June 4, 2024 with a 125:151 split ratio.
| Last Split Date | 6/4/2024 |
| Split Ratio | 125:151 |